|
Director, Bio-Analytical Development (2007002)
| Details |
Country: USA
Location: Massachusetts-Boston Cambridge 02138
Total applied: 40 Job Category:Biotech/R&D/Science
Location:Cambridge 02138
Status:Full Time, Employee
Occupations:General/Other: R&D/Science
Career Level:Manager (Manager/Supervisor of Staff)
|
|
Director, Bio-Analytical Development (2007002)
Founded in 2003, Acceleron Pharma, Inc. is a biopharmaceutical company developing therapeutics for musculoskeletal, metabolic and cancer-related diseases. In the complex and rapidly evolving field of drug discovery and development, the depth of the team and the way the team members work together are two of the most critical success factors.We have a unique culture, team, and approach that is rapidly translating our ideas and assets into drugs that will make a significant differencein patients' lives.Acceleron has raised over $85M in venture financing including $31M from our Series C financing in October 2007. We have assembled a strong management and scientific team comprised of established leaders with significant biotechnology and pharmaceutical industry experience. We are seeking talented and passionate individuals who thrive in a dynamic, `fast-paced, team-oriented and collaborative environment to be part of our success.DescriptionWe have an immediate opening at Director level for an individual responsible for leading a group of scientists (Ph.D, M.S. and B.S. level) developing immunoassays using various methods in order to measure drug (PK), anti-drug antibodies, drug neutralization, characterization of anti-drug antibodies or biomarkers evaluating drug safety or efficacy of a drug.Required SkillsProvides scientific expertise in developing new methodologies, write and review protocols, evaluate data and interface in compliance with regulatory agencies. Identify and Develop new capabilities and resources to meet both present and future needs of the group. Create an employee empowered work environment that is both stimulating and rewarding.Required ExperiencePh.D. in Biochemistry, Immunology or related field. A minimum of 5-7 years of experience in a biopharmaceutical company leading a group developing various immunoassays and interacting with regulatory agencies such as FDA, EMEA. In-depth knowledge of GLPs, SOPs and regulatory guidelines is essential. Candidate must have a proven track record and hands on experience developing various immunoassays detecting drug or drug induced antibodies. Ability to understand heterogeneous data and communicate effectively with management as well as laboratory personnel.Submitting a resume online at a job site could cause valuable screening information to be missed.
Please apply directly at:
http://hostedjobs.openhire.com/epostings/jobs/submit.cfm?fuseaction=dspjob&jobid=226934&company_id=15825&jobboardid=24
Acceleron Pharma is an Equal Opportunity Employer
|
| Related jobs |
|
|
Principal Fellow - Technical Research & Development
Novartis Institutes for BioMedical Research is Novartis' global research organization and is committed to discovering innovative medicines that cure disease and improve ...
|
|
|
Clinical Study Leader - CV
Novartis Institutes for BioMedical Research is Novartis' global research organization and is committed to discovering innovative medicines that cure disease and improve ...
|
|
|
Fellow - Biochemical & Molecular Toxicology
Novartis Institutes for BioMedical Research is Novartis' global research organization and is committed to discovering innovative medicines that cure disease and improve ...
|
|
|
Scientific Associate, In Vivo Pharmacology
Novartis Institutes for BioMedical Research is Novartis' global research organization and is committed to discovering innovative medicines that cure disease and improve ...
|
|
|
BMD Application Leader
Novartis Institutes for BioMedical Research is Novartis' global research organization and is committed to discovering innovative medicines that cure disease and improve ...
|
|
|
Manager, Compensation & Benefits
Novartis is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market ...
|
|
|
Senior Product Marketing Manager, Product Safety
Reporting to the VP of Marketing, this is an exciting opportunity to manage both the strategic and tactical product marketing efforts for the Phase Forward product ...
|
|
|
Project Manager- Clinical
Be part of a growing and thriving company in the exciting market of healthcare technology!! We design, develop, manage patient registries and post approval studies ...
|
|
|
Temporary Bioinformatics Programmer
The Temporary/Contract Bioinformatics Programmer will support development of bioinformatics capabilities across Alnylam with emphasis on sample tracking and ...
|
|
|
Field Applications Specialist SOLiD Bioinformatics - Boston
This opening is located in Boston, MAAs the leading supplier of life science technology and related applications, we are helping life scientists understand and use the ...
|
|
| Related press releases |
Courageous reform
There can be little doubt we are making progress when it comes to improving further education. More young people and adults than ever are gaining good qualifications ever...
|
|
Half of MG Rover workers want to return
Almost a year after the collapse of MG Rover, many former workers are paid less and wish they still worked for the firm, according to a report released today.
Of the nea...
|
|
Making ends meet
Earning some dosh to get through uni might seem unavoidable, but don't lose sight of the reason you are there: to get a degree. Earning shouldn't mean missing vital lectu...
|
|
|
|
The earth man cometh
I am merely the conduit,' says Patrick Holden, director of the Soil Association, when I ask him to sum up his achievement after 10 years in the job. 'The great thinkers, ...
|
|
Battle at the coalface
In his television review Rupert Smith described the NUM miners leader Arthur Scargill as "a ghastly little man who needed to be trodden on" (G2, March 23). I suppose he w...
|
|
Hutton eases small firms' pension fears
The government will not force employers to contribute to workers' pensions without making efforts to minimise the impact on firms, the work and pensions secretary, John H...
|
|
NHS hospital redundancies gather pace
A wave of redundancies across the NHS in England gathered force yesterday when a London teaching hospital announced that nearly 500 posts will be axed in an attempt to di...
|
|
Union warning over 'raw' stalls handlers
The Transport and General Workers Union (T&G) yesterday launched a fierce attack on the overall standard of the stalls handlers likely to be working at British racecourse...
|
|
Minimum wage to rise to £5.35
The minimum wage will rise by 6% in October to £5.35, the government confirmed yesterday, but it cautioned that the days of big, inflation-beating rises may be over...
|
|
|
|